Mar 14, 2024
Novel oral hormone therapy shows promising results for prostate cancer treatment with radiation therapy
Posted by Shubham Ghosh Roy in category: biotech/medical
A study led by Daniel Spratt, M.D., Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer. This work is published in JAMA Oncology.